Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Alexandra Kolliopoulou, Stavroula Siamoglou, Anne John, Argyro Sgourou, Alexandra Kourakli, Argiris Symeonidis, Efthymia Vlachaki, Panagiota Chalkia, Stamatia Theodoridou, Bassam R. Ali, Theodora Katsila, George P. Patrinos & Adamantia Papachatzopoulou. (2019) Role of Genomic Biomarkers in Increasing Fetal Hemoglobin Levels Upon Hydroxyurea Therapy and in β-Thalassemia Intermedia: A Validation Cohort Study. Hemoglobin 43:1, pages 27-33.
Read now
Read now
Florinda Listì, Serena Sclafani, Veronica Agrigento, Rita Barone, Aurelio Maggio & Elena D’Alcamo. (2018) Study on the Role of Polymorphisms of the SOX-6 and MYB Genes and Fetal Hemoglobin Levels in Sicilian Patients with β-Thalassemia and Sickle Cell Disease. Hemoglobin 42:2, pages 103-107.
Read now
Read now
Joanne Traeger-Synodinos & Cornelis L. Harteveld. (2017) Preconception carrier screening and prenatal diagnosis in thalassemia and hemoglobinopathies: challenges and future perspectives. Expert Review of Molecular Diagnostics 17:3, pages 281-291.
Read now
Read now
Mehran Karimi, Parisa Jooya, Sezaneh Haghpanah, Maral Mokhtari, Narges Rezaei, Maede Fath & Shirin Parand. (2016) Evaluation of the Relationship Between Hb F Levels and Nucleated Red Blood Cells with Morbidity in Non Transfusion-Dependent Thalassemia Patients. Hemoglobin 40:4, pages 250-256.
Read now
Read now
Alessia Finotti, Monica Borgatti, Nicoletta Bianchi, Cristina Zuccato, Ilaria Lampronti & Roberto Gambari. (2016) Orphan Drugs and Potential Novel Approaches for Therapies of β-Thalassemia: Current Status and Future Expectations. Expert Opinion on Orphan Drugs 4:3, pages 299-315.
Read now
Read now
Giulia Breveglieri, Alessia Finotti, Monica Borgatti & Roberto Gambari. (2015) Recent patents and technology transfer for molecular diagnosis of β-thalassemia and other hemoglobinopathies. Expert Opinion on Therapeutic Patents 25:12, pages 1453-1476.
Read now
Read now
Raffaella Origa, Alessandro Baldan, Maria Marsella & Caterina Borgna-Pignatti. (2015) A complicated disease: what can be done to manage thalassemia major more effectively?. Expert Review of Hematology 8:6, pages 851-862.
Read now
Read now
Mehrnoush Kosaryan, Mandana Zafari, Abbass Alipur & Akbar Hedayatizadeh-Omran. (2014) The Effect and Side Effect of Hydroxyurea Therapy on Patients With β-Thalassemia: A Systematic Review to December 2012. Hemoglobin 38:4, pages 262-271.
Read now
Read now
Mehdi Banan, Hadi Bayat, Pegah Namdar-Aligoodarzi, Azita Azarkeivan, Koorosh Kamali, Parvaneh Daneshmand, Behzad Zaker-Kandjani & Hossein Najmabadi. (2013) Utility Of The Multivariate Approach In Predicting β-Thalassemia Intermedia Or β-Thalassemia Major Types In Iranian Patients. Hemoglobin 37:5, pages 413-422.
Read now
Read now
Articles from other publishers (24)
Urmimala Bhattacharjee, Alka Khadwal, Nusrat Shafiq, Deepesh Lad, Prashant Sharma, Reena Das, Prateek Shukla, Arihant Jain, Gaurav Prakash & Pankaj Malhotra. (2023) A Phase 2 Randomized Controlled Trial of Single-Agent Hydroxyurea Versus Thalidomide Among Adult Transfusion Dependent β Thalassemia Patients. Indian Journal of Hematology and Blood Transfusion.
Crossref
Crossref
Kongtana Trakarnsanga, Nontaphat Thongsin, Chanatip Metheetrairut, Chartsiam Tipgomut, Saiphon Poldee & Methichit Wattanapanitch. (2022) Genetic correction of haemoglobin E in an immortalised haemoglobin E/beta-thalassaemia cell line using the CRISPR/Cas9 system. Scientific Reports 12:1.
Crossref
Crossref
Saqib H. Ansari, Zeeshan Hussain, Muhammad Zohaib, Sadia Parveen, Bushra Kaleem, Hina Qamar, Omair Adil, Muhammad T. Khan & Tahir S. Shamsi. (2022) A Pragmatic Scoring Tool to Predict Hydroxyurea Response Among β-Thalassemia Major Patients in Pakistan. Journal of Pediatric Hematology/Oncology 44:1, pages e77-e83.
Crossref
Crossref
Mehran Karimi, Tahereh Zarei, Ardeshir Bahmanimehr, Azam Aramesh, Saeed Daryanoush & Sezaneh Haghpanah. (2021) Long-term safety and efficacy of hydroxyurea in patients with non-transfusion-dependent β-thalassemia: a comprehensive single-center experience. Annals of Hematology 100:12, pages 2901-2907.
Crossref
Crossref
Ali Dehshahri, Alessio Biagioni, Hadi Bayat, E. Hui Clarissa Lee, Mohammad Hashemabadi, Hojjat Samareh Fekri, Ali Zarrabi, Reza Mohammadinejad & Alan Prem Kumar. (2021) Editing SOX Genes by CRISPR-Cas: Current Insights and Future Perspectives. International Journal of Molecular Sciences 22:21, pages 11321.
Crossref
Crossref
Kariofyllis Karamperis, Maria T. Tsoumpeli, Fotios Kounelis, Maria Koromina, Christina Mitropoulou, Catia Moutinho & George P. Patrinos. (2021) Genome-based therapeutic interventions for β-type hemoglobinopathies. Human Genomics 15:1.
Crossref
Crossref
Kun Yang, Yi Wu, Yanni Ma, Jian Xiao, Yali Zhou & Xiaolin Yin. (2020) The association of HBG2, BCL11A, and HBS1L-MYB polymorphisms to thalidomide response in Chinese β-thalassemia patients. Blood Cells, Molecules, and Diseases 84, pages 102442.
Crossref
Crossref
Apostolos Stratopoulos, Alexandra Kolliopoulou, Kariofyllis Karamperis, Anne John, Kyriaki Kydonopoulou, George Esftathiou, Argyro Sgourou, Alexandra Kourakli, Efthimia Vlachaki, Panagiota Chalkia, Stamatia Theodoridou, Manoussos N Papadakis, Spyridon Gerou, Argiris Symeonidis, Theodora Katsila, Bassam R Ali, Adamantia Papachatzopoulou & George P Patrinos. (2019) Genomic variants in members of the Krüppel-like factor gene family are associated with disease severity and hydroxyurea treatment efficacy in β-hemoglobinopathies patients. Pharmacogenomics 20:11, pages 791-801.
Crossref
Crossref
Hossein Jafari, Sara Hesami, Mojtaba Safi, Fatemeh Ghasemi & Mehdi Banan. (2019) Expression and hydroxyurea-triggered induction of EGFP upon CRISPR/Cas9-mediated integration into the γ-globin gene of K562 cells. Biotechnology Letters 41:6-7, pages 691-700.
Crossref
Crossref
Sarah T. Diepstraten & Adam H. Hart. (2019) Modelling human haemoglobin switching. Blood Reviews 33, pages 11-23.
Crossref
Crossref
Sètondji Cocou Modeste Alexandre Yahouédéhou, Elisângela Vitória Adorno, Caroline Conceição da Guarda, Uche Samuel Ndidi, Suellen Pinheiro Carvalho, Rayra Pereira Santiago, Milena Magalhães Aleluia, Rodrigo Mota de Oliveira & Marilda de Souza Gonçalves. (2018) Hydroxyurea in the management of sickle cell disease: pharmacogenomics and enzymatic metabolism. The Pharmacogenomics Journal 18:6, pages 730-739.
Crossref
Crossref
Giulia Breveglieri, Nicoletta Bianchi, Lucia Carmela Cosenza, Maria Rita Gamberini, Francesco Chiavilli, Cristina Zuccato, Giulia Montagner, Monica Borgatti, Ilaria Lampronti, Alessia Finotti & Roberto Gambari. (2017) An Aγ-globin G->A gene polymorphism associated with β039 thalassemia globin gene and high fetal hemoglobin production. BMC Medical Genetics 18:1.
Crossref
Crossref
Nahal Maroofi, Azita Azarkeivan, Soosan Banihashemi, Saeid Mohammadparast, Ali Aghajanirefah & Mehdi Banan. (2017)
An enhancer haplotype may influence
BCL11A
expression levels and the response to hydroxyurea in β-thalassemia patients
. Pharmacogenomics 18:10, pages 995-967.
Crossref
Crossref
Mehran Karimi, Tahereh Zarei, Sezaneh Haghpanah, Mohamad Moghadam, Ahmad Ebrahimi, Narges Rezaei, Ghazaleh Heidari, Afsaneh Vazin, Maryam Khavari & Hamid R. Miri. (2017) Relationship Between Some Single-nucleotide Polymorphism and Response to Hydroxyurea Therapy in Iranian Patients With β-Thalassemia Intermedia. Journal of Pediatric Hematology/Oncology 39:4, pages e171-e176.
Crossref
Crossref
Serena Sclafani, Alice Pecoraro, Veronica Agrigento, Antonio Troia, Rosario Di Maggio, Massimiliano Sacco, Aurelio Maggio, Elena D'Alcamo & Rosalba Di Marzo. (2016) Study on Hydroxyurea Response in Hemoglobinopathies Patients Using Genetic Markers and Liquid Erythroid Cultures. Hematology Reports 8:4, pages 56-60.
Crossref
Crossref
Lantip Rujito, Muhammad Basalamah, Wahyu Siswandari, Joko Setyono, Gondo Wulandari, Sri Mulatsih, Abdul Salam M. Sofro, Ahmad Hamim Sadewa & Sutaryo Sutaryo. (2016) Modifying effect of XmnI, BCL11A, and HBS1L-MYB on clinical appearances: A study on β-thalassemia and hemoglobin E/β-thalassemia patients in Indonesia. Hematology/Oncology and Stem Cell Therapy 9:2, pages 55-63.
Crossref
Crossref
Nicoletta Bianchi, Lucia Carmela Cosenza, Ilaria Lampronti, Alessia Finotti, Giulia Breveglieri, Cristina Zuccato, Enrica Fabbri, Giovanni Marzaro, Adriana Chilin, Gioia De Angelis, Monica Borgatti, Cristiano Gallucci, Cecilia Alfieri, Michela Ribersani, Antonella Isgr?Marco Marziali, Javid Gaziev, Aldo Morrone, Pietro Sodani, Guido Lucarelli, Roberto Gambari & Katia Paciaroni. (2016) Structural and Functional Insights on an Uncharacterized A?-Globin-Gene Polymorphism Present in Four ?0-Thalassemia Families with High Fetal Hemoglobin Levels. Molecular Diagnosis & Therapy 20:2, pages 161-173.
Crossref
Crossref
Edouard de Dreuzy, Kanit Bhukhai, Philippe Leboulch & Emmanuel Payen. (2016) Current and future alternative therapies for beta-thalassemia major. Biomedical Journal 39:1, pages 24-38.
Crossref
Crossref
Aikaterini Gravia, Vasiliki Chondrou, Theodora Katsila & George P. Patrinos. 2015. Preventive and Predictive Genetics: Towards Personalised Medicine. Preventive and Predictive Genetics: Towards Personalised Medicine
157
171
.
Aikaterini Gravia, Vasiliki Chondrou, Argyro Sgourou, Ioanna Papantoni, Joseph Borg, Theodora Katsila, Adamantia Papachatzopoulou & George P Patrinos. (2014) Individualizing fetal hemoglobin augmenting therapy for β-type hemoglobinopathies patients. Pharmacogenomics 15:10, pages 1355-1364.
Crossref
Crossref
Abbas Najjari, Mohsen Asouri, Ladan Hosseini Gouhari, Haleh Akhavan Niaki, Amir Sasan Mozaffari Nejad, Seyyedeh Masoumeh Eslami, Hassan Abolghasemi, Ramin Ataee, Abdol Ali Ebrahimi, Masoumeh Rezaei Moshaei & Ali Asghar Ahmadi. (2014) α:Non–α and Gγ:Aγ globin chain ratios in thalassemia intermedia patients treated with hydroxyurea. Asian Pacific Journal of Tropical Biomedicine 4, pages S177-S185.
Crossref
Crossref
Junghyun ParkShambhunath BoseSun-Woo HongDong-Ki LeeJae-Wook YooChi-Yeon LimMyeongjong LeeHojun Kim. (2014)
Impact of GNB3-C825T, ADRB3-Trp64Arg, UCP2-3′UTR 45 bp del/ins, and PPARγ-Pro12Ala Polymorphisms on
Bofutsushosan
Response in Obese Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial
. Journal of Medicinal Food 17:5, pages 558-570.
Crossref
Crossref
Khaled M. MusallamAli T. TaherMaria Domenica CappelliniVijay G. Sankaran. (2013) Clinical experience with fetal hemoglobin induction therapy in patients with β-thalassemia. Blood 121:12, pages 2199-2212.
Crossref
Crossref
Mehdi Banan. (2013) Hydroxyurea treatment in β-thalassemia patients: to respond or not to respond?. Annals of Hematology 92:3, pages 289-299.
Crossref
Crossref